4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001737287-25-000004
President and CEO acquired 552,174 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chang David D · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-24 | Grant or award : show line 1 in the form | +552,174 | 5,363,240 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-24 | Grant or award : show line 2 in the form Stock Option (Right to buy) | +1,952,130 | 1,952,130 | D |
Loading xslF345X05/wk-form4_1738113042.xml…